Longevity Health Holdings, Inc. (XAGE) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-2.45M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.36× | Operating cash flow / net income. Period ending 2026-06-30. $-2.45M ÷ $-6.83M ≈ 0.36× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -2.45M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 1.69M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -6.83M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $-2.45M | (m) | (m) | $1.69M | (m) | $-6.83M | (m) | (m) | (m) | 0.36× |
| 2026-03-31 | (m) | (m) | $-3.06M | (m) | (m) | $1.79M | (m) | $-6.83M | (m) | (m) | (m) | 0.45× |
| 2025-12-31 | $-3.34M | (m) | $-3.33M | $14.22K | (m) | $1.91M | (m) | $-6.91M | (m) | (m) | -174.79% | 0.48× |
| 2025-09-30 | (m) | (m) | $-4.29M | (m) | (m) | $1.46M | (m) | $-5.74M | (m) | (m) | (m) | 0.75× |
| 2025-06-30 | (m) | (m) | $-3.76M | (m) | (m) | $1.05M | (m) | $-7.19M | (m) | (m) | (m) | 0.52× |
| 2025-03-31 | (m) | (m) | $-4.07M | (m) | (m) | $560.67K | (m) | $-8.60M | (m) | (m) | (m) | 0.47× |
| 2024-12-31 | (m) | (m) | $-4.39M | (m) | (m) | $50.32K | (m) | $-10.37M | (m) | (m) | (m) | 0.42× |
| 2024-09-30 | (m) | (m) | $-7.03M | (m) | (m) | (m) | (m) | $-6.30M | (m) | (m) | (m) | 1.12× |
| 2024-06-30 | (m) | (m) | $-9.61M | (m) | (m) | (m) | (m) | $-14.88M | (m) | (m) | (m) | 0.65× |
| 2024-03-31 | (m) | (m) | $-8.95M | (m) | (m) | (m) | (m) | $-16.89M | (m) | (m) | (m) | 0.53× |
| 2023-12-31 | $-8.38M | (m) | $-8.35M | $30.47K | (m) | (m) | (m) | $-15.45M | (m) | (m) | (m) | 0.54× |
| 2023-09-30 | (m) | (m) | $-4.56M | (m) | (m) | (m) | (m) | $-12.46M | (m) | (m) | (m) | 0.37× |
| 2023-06-30 | (m) | (m) | $-471.25K | (m) | (m) | (m) | (m) | $1.97M | (m) | (m) | (m) | -0.24× |
| 2023-03-31 | (m) | (m) | $-508.60K | (m) | (m) | (m) | (m) | $1.31M | (m) | (m) | (m) | -0.39× |
| 2022-12-31 | (m) | (m) | $-488.74K | (m) | (m) | (m) | (m) | $205.00K | (m) | (m) | (m) | -2.38× |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |